Abstract

TGFβ induces fibrosis in healing corneal wounds, and in vitro corneal keratocytes up-regulate expression of several fibrosis-related genes in response to TGFβ. Hyaluronan (HA) accumulates in healing corneas, and HA synthesis is induced by TGFβ by up-regulation of HA synthase 2. This study tested the hypothesis that HA acts as an extracellular messenger, enhancing specific fibrotic responses of keratocytes to TGFβ. HA synthesis inhibitor 4-methylumbelliferone (4MU) blocked TGFβ induction of HA synthesis in a concentration-dependent manner. 4MU also inhibited TGFβ-induced up-regulation of α-smooth muscle actin, collagen type III, and extra domain A-fibronectin. Chemical analogs of 4MU also inhibited fibrogenic responses in proportion to their inhibition of HA synthesis. 4MU, however, showed no effect on TGFβ induction of luciferase by the 3TP-Lux reporter plasmid. Inhibition of HA using siRNA to HA synthase 2 reduced TGFβ up-regulation of smooth muscle actin, fibronectin, and cell division. Similarly, brief treatment of keratocytes with hyaluronidase reduced TGFβ responses. These results suggest that newly synthesized cell-associated HA acts as an extracellular enhancer of wound healing and fibrosis in keratocytes by augmenting a limited subset of the cellular responses to TGFβ.

Highlights

  • Along with this transition, atypical components of the extracellular matrix are observed, including hyaluronan, biglycan, the extra domain A (EDA) splice form of fibronectin, collagen types I and III, and SPARC [1,2,3,4,5]

  • Myofibroblasts exhibit reduced synthesis of keratan sulfate and abundant secretion of extracellular matrix-containing components identified in corneal scars

  • These results show that the potency of these compounds for blocking TGF␤-induced EDA-FN and ␣SMA accumulation correlates with their ability to block HA synthesis

Read more

Summary

Introduction

Atypical components of the extracellular matrix are observed, including hyaluronan, biglycan, the extra domain A (EDA) splice form of fibronectin, collagen types I and III, and SPARC (secreted protein acidic and rich in cysteine) [1,2,3,4,5]. Primary bovine keratocytes were untreated (first four samples) or treated with 2 ng/ml TGF␤ in 1% platelet-poor horse serum for 4 days, and mRNA levels were determined by quantitative reverse transcriptase PCR as described under “Materials and Methods.” 4MU was present during treatment at the concentrations noted.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call